Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome - Streetwise Reports

Submitted by Anonymous (not verified) on Mon, 12/16/2019 - 19:36

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome  Streetwise Reports